debrisoquin has been researched along with meprobamate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Sternon, J | 1 |
| Alvan, G; Dalén, P; Olsen, H; Wakelkamp, M | 1 |
3 other study(ies) available for debrisoquin and meprobamate
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
[The practitioner and drug-induced, predominantly orthostatic hypotension].
Topics: Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Antipsychotic Agents; Barbiturates; Butyrophenones; Clonidine; Debrisoquin; Diazoxide; Diuretics; Ganglionic Blockers; Humans; Hydralazine; Hypotension, Orthostatic; Levodopa; Meprobamate; Methyldopa; Mineralocorticoids; Monoamine Oxidase Inhibitors; Phenothiazines; Prazosin; Psychotropic Drugs; Reserpine; Vasodilator Agents | 1978 |
Formation of meprobamate from carisoprodol is catalysed by CYP2C19.
Topics: Administration, Oral; Adult; Analgesics; Aryl Hydrocarbon Hydroxylases; Carisoprodol; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Debrisoquin; Female; Humans; Inactivation, Metabolic; Male; Mephenytoin; Meprobamate; Metabolic Clearance Rate; Middle Aged; Mixed Function Oxygenases; Muscle Relaxants, Central | 1996 |